Petros Grivas
Full Professor(heuristic)
Bladder and Urothelial Cancer Treatments · Surgery
Compare more Surgery professors.
h-index62
i10-index279
Publications910
Citations25,240
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus (ESMO Open)2026-06-12
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0003-3965-3394